From product releases and developments to attending international pharmaceutical trade shows and new partnerships... Find out more about the group’s key events here.
Stiplastics will be exhibiting at the CPhI, international pharmaceutical industry show in Frankfurt, Germany from 24 to 26 October 2017. Come and meet us on stand 42J42 to find out more about our standard range and smart solutions for the pharmacy and health sectors.
Find the new Pilbox Cardio on https://www.cphi.com/.
Join us in Montpellier on 21 and 22 October 2017, at the French National Pharmacists’ Congress on stand A8 and meet the VisionAIR Plus team responsible for Stiplastics’ respiratory diseases brand.
Find the new Pilbox Cardio on http://congresdespharmaciens.org.
Pilbox will be exhibiting at the Expopharm show in Düsseldorf, Germany from 13 to 16 September 2017. Find our range of practical, contemporary pill dispensers at our local distributor ApoTeam’s stand K15 in hall 5.
Find the new Pilbox Cardio on http://expopharm.eu/.
Stiplastics is investing €5 million to combine all its activities on a single site. The company built a unit providing additional capacity and assembly facilities in 2015, on a two-hectare plot bought in 2014. In 2017, the administrative teams and injection site (previously in Beauvoir-en-Royans) joined the single 10,000 m2 site in Saint-Marcellin. The company will have invested a total of €8.6 million – €2.1 million for the first tranche, €1.5 million for the offices and €5 million for the final tranche – on modernising its production facilities to remain competitive in the health sector.
Pilbox celebrates the start of the new year with its new, portable pill dispenser: the Pilbox Cardio.
The new dispenser is designed for treating and monitoring cardiovascular diseases. The weekly dispenser, which features seven separate modules with four compartments in each, can be used to store and keep track of pills and sachets. It is therefore designed for people taking treatments that include several different medicines. It also has two storage areas, one for sachets (or items such as health or top-up insurance and blood-group cards) and another for prescriptions, as well as a handy jotter for noting down medical information.
This compact, easy-to-use pill dispenser helps our customers to keep track of their treatments and remember when to take them, making it ideal for people who are active and on the move. Its imitation leather design and new powder pink and grey colours make it an on-trend accessory.
And as an added bonus: the magnetic clasp is easy to manipulate and the new dispenser adapts easily to different numbers of sachets.
Find the new Pilbox Cardio on www.pilbox.co.uk.
True to its philosophy of improving comfort and ease of use for medical analysis laboratories and their patients, Hemobox is extending its dedicated biological analysis range with an all-new “yellow box” sharps container.
The container is delivered in kit form for easy storage and optimal transport prior to use, ready to be assembled in seconds.
The range of containers is available in different sizes and complies with the ISO regulations in effect (EN 23907:2012, NFX 30-511, ADR, RID and IMDG approved). It will be marketed in early 2017.
Find out more at www.hemobox.com.
The Rhinophar nasal aspirator, an own brand made available to pharmaceutical laboratories, is continuing to be rolled out in Europe. Following Italy and Portugal, Switzerland, Liechtenstein and Belgium have joined the ranks of our customers for this class 1 medical device. Stiplastics has perfected its understanding of rhinopharyngeal decongestion to offer a high-performance nasal aspirator, with easy-to-replace filters, which guarantees comfortable aspiration.
Download the Rhinophar product information sheet.
Three new representatives have joined the sales teams to support Stiplastics’ new organisation and ambitions. Béatrice Genetiot joins the Stimed division led by Kristen Le Nouy. Béatrice is responsible for standard products for the French and export markets.
At Sticare, the business unit managed by Virginie Delay: